1. Home
  2. BCML vs LUNG Comparison

BCML vs LUNG Comparison

Compare BCML & LUNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BayCom Corp

BCML

BayCom Corp

HOLD

Current Price

$29.73

Market Cap

364.8M

Sector

Finance

ML Signal

HOLD

Logo Pulmonx Corporation

LUNG

Pulmonx Corporation

HOLD

Current Price

$1.99

Market Cap

97.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BCML
LUNG
Founded
2004
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Industrial Specialties
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
364.8M
97.1M
IPO Year
2018
2020

Fundamental Metrics

Financial Performance
Metric
BCML
LUNG
Price
$29.73
$1.99
Analyst Decision
Strong Buy
Buy
Analyst Count
1
7
Target Price
$34.00
$5.38
AVG Volume (30 Days)
35.5K
321.2K
Earning Date
04-23-2026
04-29-2026
Dividend Yield
4.09%
N/A
EPS Growth
3.81
7.64
EPS
0.11
N/A
Revenue
N/A
$90,497,000.00
Revenue This Year
$13.71
$2.48
Revenue Next Year
$5.25
$18.46
P/E Ratio
$272.95
N/A
Revenue Growth
N/A
8.01
52 Week Low
$26.78
$1.13
52 Week High
$34.98
$2.89

Technical Indicators

Market Signals
Indicator
BCML
LUNG
Relative Strength Index (RSI) 43.85 47.86
Support Level $29.57 $1.20
Resistance Level $30.89 $2.16
Average True Range (ATR) 0.54 0.13
MACD 0.03 -0.03
Stochastic Oscillator 28.57 32.26

Price Performance

Historical Comparison
BCML
LUNG

About BCML BayCom Corp

BayCom Corp is a bank holding company for United Business Bank. It provides a broad range of financial services to businesses and business owners as well as individuals through its full-service branches and loan production office. The company targets its services to small and medium-sized businesses, professional firms, real estate professionals, nonprofit businesses, labor unions, and related nonprofit entities and businesses, and individual consumers. Its products and services include deposit products, personal accounts, loans, online banking, cash management, and business savings services. The Company operates as one reportable segment: banking operations.

About LUNG Pulmonx Corporation

Pulmonx Corp is a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). solution, which is comprised of the Zephyr Endobronchial Valve (Zephyr Valve), the Chartis Pulmonary Assessment System (Chartis System), and the LungTraX Platform, is designed to treat severe emphysema patients who, despite medical management, are still profoundly symptomatic and either do not want or are ineligible for surgical approaches. The majority of the company's revenue is generated from the provision of cloud hosting and management services. The company geographically, operates in the USA, the EMEA, the Asia Pacific, and other international regions, the majority of revenue from USA.

Share on Social Networks: